osimertinib,tepotinib
merck,astrazeneca
[]
 ok. here s the thing. the real orr is 15% less than the reported in a single arm, selected population. that falls within the upper limit of chemo activity. uncertainties about risks/benefits will remain until ph3 rct is done. payers aren t willing to pay until they see the data
Medical Oncology ?? HGU Gregorio Marañón?@myESMO Faculty ?? Lung Cancer - Mesothelioma - Thymoma?Power to the patients #endlungcancer #lcsm